B4 Capital — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Notable Labs operates an automated laboratory that tests combinations of existing drugs against individual patients' blood cancer cells to identify effective treatment options for patients whose cancers have become resistant to standard therapies.
BiotechHealthtechMedical DevicesSan Francisco, US
Matthew De Silva(Founder/CEO)inPete Quinzio(Founder)in
Board seatAdam Seabrook· per SEC Form D · $10.3M raise · filed Mar 2023
Co-investors11.2 CapitalBuilders VCFundersClubHemisphere Ventures LLCLifeforce CapitalY Combinator+3 more
An AI-powered answer engine providing accurate, trusted, and real-time answers to questions.
San Francisco, US
Andrew D. Konwinski(Executive Officer, Director)Dzianis Yarats(Director)Aravind Srinivas Lakshminarayanan(Director, Executive Officer)Aravind Srinivas(Co-founder & CEO)inDenis Yarats(Co-founder & CTO)
BoardPeter Sonsini(Director)
Co-investors359 Capital7BC Venture CapitalAccelAdvaita CapitalAIX VenturesArrington Capital+49 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.